Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients

British Journal of Clinical Pharmacology
Henrik AgersøThomas Senderovitz

Abstract

To evaluate the influence of renal impairment on the pharmacokinetics of desmopressin. Twenty-four subjects were enrolled in the study, 18 with varying degrees of renal impairment and six healthy volunteers. Each subject received a single intravenous dose of 2 microg desmopressin. Blood and urine samples were collected for 24 h and assayed for desmopressin by radioimmunoassay. Plasma concentrations and the amounts of desmopressin excreted in the urine were analysed simultaneously by use of mixed effects modelling. Only mild adverse events were observed. Both the renal and the nonrenal clearance of desmopressin were found to vary with the creatinine clearance (CrCL). A decrease of 1.67% in the CrCL (corresponding to 1 ml min(-1) from 60 ml min(-1)) was found to cause a 1.74% decrease in the renal clearance and a 0.93% decrease in the nonrenal clearance. The fall in renal clearance caused the amount of desmopressin excreted in urine to decrease from 47% in healthy subjects to 21% in the patients with severe renal impairment. The mean systemic clearance of desmopressin was 10 litres h(-1) in healthy subjects and 2.9 litres h(-1) in patients with severe renal impairment (difference -7.5 litres h(-1), 95% CI [-11; -4.3] litres h(-1)...Continue Reading

References

Jan 1, 1992·Scandinavian Journal of Urology and Nephrology·R Asplund, H E Aberg
Feb 1, 1992·Archives of Disease in Childhood·J H Evans, S R Meadow
Jun 1, 1992·Scandinavian Journal of Primary Health Care·R Asplund, H Aberg
Nov 1, 1988·Clinical Pharmacokinetics·W M Bennett
Oct 1, 1986·Acta Pharmacologica Et Toxicologica·N A AunsholtE B Schmidt
Jul 1, 1971·Journal of the American Geriatrics Society·J C BrocklehurstG Kalton
Dec 3, 1983·British Medical Journal·J L KirklandA K Banerjee
Mar 1, 1984·Biochemical Pharmacology·S E Patterson, V H Cohn
Jun 1, 1982·British Journal of Urology·P Hilton, S L Stanton
Dec 1, 1994·British Journal of Urology·S D EckfordP H Abrams
Dec 5, 1998·British Journal of Urology·R AsplundP Bengtsson
Mar 12, 1999·Journal of the American Society of Nephrology : JASN·S NielsenD Marples
Apr 9, 1999·Computer Methods and Programs in Biomedicine·E N Jonsson, M O Karlsson
Aug 12, 1999·BJU International·A CannonP Abrams
Aug 19, 2000·Journal of Pharmacokinetics and Biopharmaceutics·T CallréusP Höglund
Apr 12, 2001·European Journal of Internal Medicine·W J. Mulder, H F.P. Hillen
May 7, 2003·Clinical Pharmacology and Therapeutics·Thomas C DowlingWilliam L Henrich

❮ Previous
Next ❯

Citations

May 6, 2005·European Journal of Clinical Pharmacology·Torbjörn CallréusMorten Andersen
Jan 9, 2008·European Journal of Clinical Pharmacology·Rickard Ljung
Mar 20, 2010·Pharmaceutical Research·Keizo FukushimaKanji Takada
Feb 10, 2012·Analytical and Bioanalytical Chemistry·Simone EspositoPeter Van Eenoo
Jul 9, 2010·Advances in Chronic Kidney Disease·Sarinya BoongirdMark L Unruh
Jan 17, 2012·British Journal of Clinical Pharmacology·David CzockHanna M Seidling
Jun 29, 2012·Biomedical Chromatography : BMC·Simone EspositoPeter Van Eenoo
Apr 17, 2013·Basic & Clinical Pharmacology & Toxicology·Bill VestergaardJens Lykkesfeldt
Mar 17, 2016·HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery·James S MacKenzie, Stuart C Kozinn
Apr 24, 2016·Clinical Pharmacokinetics·Robin MicheletAn Vermeulen
Apr 28, 2016·Acta Anaesthesiologica Scandinavica·E BignamiG Landoni
Feb 2, 2017·Scientific Reports·Maria Giulia Di GiglioChristian W Gruber
Oct 20, 2017·Expert Review of Clinical Pharmacology·Joshua A CohnAlan J Wein
Apr 18, 2007·Pharmacoepidemiology and Drug Safety·Torbjörn Callréus
Apr 28, 2019·International Urology and Nephrology·Cynthia C LimChieh Suai Tan
Sep 7, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yeamin HuhMeihau Rose Feng
Jul 22, 2016·American Journal of Physiology. Renal Physiology·Wataru YoshiokaChiharu Tohyama
Mar 4, 2011·American Journal of Physiology. Renal Physiology·Kristian Vinter JuulJens Peter Nørgaard
Jul 1, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Domenic A Sica, Todd W B Gehr
Jun 9, 2020·Paediatric Drugs·Elke GasthuysJohan Vande Walle
Mar 4, 2020·International Journal of Oncology·Romina Gabriela ArmandoDaniel Eduardo Gomez
Apr 3, 2021·Nature Biomedical Engineering·Ava M VargasonSamir Mitragotri
Apr 26, 2019·Journal of Medicinal Chemistry·Kazimierz WiśniewskiClaudio D Schteingart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.